Author: admin

The Boulder Group Arranges Sale of Net Leased CVS Pharmacy Property in the Chicago MSA

Randy Blankstein and Jimmy Goodman of The Boulder Group represented the seller in the transaction.

The Boulder Group, a net leased investment brokerage firm, completed the sale of a single tenant net leased CVS Pharmacy property located at 19900 LaGrange Road in Mokena, Illinois for $5,302,000.

The 13,225 square foot CVS Pharmacy property benefits from its location at the signalized intersection of West La Porte Road and LaGrange Road/U.S. Route 45, which experiences a traffic count of 36,000 vehicles per day. The property is situated less than 2 miles south of Interstate 80, which has a traffic count of 116,000 vehicles per day.

Notable retailers nearby include Home Depot, ALDI, Staples, Goodwill, Brookhaven Market, Urban Air Trampoline and Adventure Park, Emagine, AutoZone, Dollar Tree, Speedway, Belle Tire, O’Reilly Auto Parts, Sherwin-Williams, Chick-fil-A, Taco Bell, and Jimmy John’s. Lincoln-Way East High School (2,700+ students) is situated less than 2 miles from the subject property. The population is 136,211 within a five-mile radius, with a robust average annual household income of $143,897.

This triple net lease has over 9 years of term remaining with ten 5-year renewal options. There are 5% rental escalations beginning at the start of the second renewal option.

Randy Blankstein and Jimmy Goodman of The Boulder Group represented the seller in the transaction. The buyer is a 1031 investor based in California and the seller is a commercial real estate investor based in Texas.

CVS Pharmacy is a leading healthcare and retail company in the United States, known for providing a wide range of pharmaceutical services, health products, and wellness solutions. CVS has over 9,000 locations throughout the United States and is ranked #5 in the Fortune 500.

“CVS Pharmacy properties with extensive operating histories continue to garner significant investor interest” said Randy Blankstein, President of The Boulder Group. Jimmy Goodman, Partner at The Boulder Group, added, “This deal signifies that CVS remains a desirable tenant to many investors despite recent challenges in the drug store sector.”

About The Boulder Group

The Boulder Group is a boutique investment real estate service firm specializing in single tenant net lease properties. The firm provides a full range of brokerage, advisory, and financing services nationwide to a substantial and diversified client base, which includes high-net-worth individuals, developers, REITs, partnerships and institutional investment funds. Founded in 1997, the firm has arranged the acquisition and disposition of over $9 billion of single tenant net lease real estate transactions. From 2013-2024, the firm was ranked in the top 10 companies in the nation for single tenant retail transactions by both Real Capital Analytics and CoStar. The Boulder Group is headquartered in suburban Chicago and has an office in Denver.

www.bouldergroup.com

Media Contact
Company Name: The Boulder Group
Contact Person: Randy Blankstein
Email: Send Email
Phone: 8478816388
Address:3520 Lake Avenue Suite 203
City: Wilmette
State: Illinois
Country: United States
Website: https://www.bouldergroup.com/NNN-Properties-For-Sale.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: The Boulder Group Arranges Sale of Net Leased CVS Pharmacy Property in the Chicago MSA

Biliary Tract Cancer Clinical Trials, Companies, Therapeutic Assessment, Therapies, Treatment Algorithm, and Pipeline Analysis | Yantai Rongchang Pharmaceutical, RemeGen, EMD Serono, SMT bio Co., Ltd.

“Biliary Tract Cancers (BTCs) Pipeline Insight”
DelveInsight’s, “Biliary Tract Cancers (BTCs) – Pipeline Insight, 2025,” report provides comprehensive insights about 80+ companies and 80+ pipeline drugs in Biliary Tract Cancers (BTCs) pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

DelveInsight reports that more than 80 prominent companies are currently involved in the development of over 80 potential therapies targeting biliary tract cancer.

Biliary Tract Cancer Overview:

Biliary tract cancer develops in the cells lining the bile ducts, gallbladder, or ampulla of Vater. When it affects the bile ducts specifically, it is referred to as cholangiocarcinoma and is classified based on its location: intrahepatic (within the liver), hilar (at the convergence of the left and right hepatic ducts), or extrahepatic (outside the liver, involving the common bile duct). Each form has distinct clinical features, genetic mutations, and risk factors. Diagnosis typically relies on imaging methods such as ultrasound, CT scans, MRI, and MRCP. Surgery is the only curative treatment available, although recurrence is common. Chemotherapy and radiotherapy are frequently used as additional therapies. Emerging advancements in targeted treatments, immunotherapies, and molecular research—particularly in the adjuvant and neoadjuvant settings—are offering new hope for enhancing survival and quality of life in affected patients.

Request for a detailed insights report on Biliary Tract Cancer pipeline insights

“Biliary Tract Cancer Pipeline Insight 2025” report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the Biliary Tract Cancer Therapeutics Market.

Key Takeaways from the Biliary Tract Cancer Pipeline Report

  • DelveInsight’s Biliary Tract Cancer pipeline report depicts a robust space with 80+ active players working to develop 80+ pipeline therapies for Biliary Tract Cancer treatment.

  • In November 2025, Jazz Pharmaceuticals plc announced that the U.S. Food and Drug Administration (FDA) granted accelerated approval for Ziihera® (zanidatamab-hrii) 50mg/mL intravenous injection to treat adults with previously treated, unresectable, or metastatic HER2-positive (IHC 3+) biliary tract cancer (BTC), identified through an FDA-approved test. Ziihera received this approval based on a 52% objective response rate (ORR) and a median duration of response (DOR) of 14.9 months, as assessed by independent central review. Continued approval may depend on confirming clinical benefit in a follow-up trial. The Phase 3 HERIZON-BTC-302 trial is ongoing to assess zanidatamab in combination with standard therapy versus standard therapy alone in first-line treatment of HER2-positive BTC.

  • In August 2025, Compass Therapeutics, Inc. announced the completion of patient enrollment in its COMPANION-002 trial. This randomized Phase 2/3 study, involving 150 patients, evaluates CTX-009 in individuals with biliary tract cancer (BTC).

  • In June 2025, Bold Therapeutics shared positive Phase 2 safety and efficacy results for its lead treatment, BOLD-100, for advanced metastatic biliary tract cancer (BTC) and gastric cancer (GC) at the American Society of Clinical Oncology (ASCO) annual meeting.

  • Key Biliary Tract Cancer companies such as Yantai Rongchang Pharmaceutical, RemeGen, EMD Serono, SMT bio Co., Ltd., CSPC ZhongQi Pharmaceutical Technology Co., Ltd., InnoPharmax Inc., Lee’s Pharmaceutical Limited, Hoffmann-La Roche, Shanghai Miracogen Inc., Zymeworks Inc., Bristol-Myers Squibb, Eli Lilly and Company, Ipsen, Threshold Pharmaceuticals, Leap Therapeutics, Hutchison Medipharma Limited, Array BioPharma, Redx Pharma Plc, Compass Therapeutics, Lee’s Pharmaceutical Limited, and others are evaluating new drugs for Biliary Tract Cancer to improve the treatment landscape.

  • Promising Biliary Tract Cancer pipeline therapies in various stages of development include MRG 002, Disitamab vedotin, Envafolimab, DKN-01, and others.

Biliary Tract Cancer Pipeline Analysis

The report provides insights into:

  • The report provides detailed insights into the key companies that are developing therapies in the Biliary Tract Cancer Market.

  • The report also evaluates different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Biliary Tract Cancer treatment.

  • It analyzes the key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.

  • It navigates the emerging drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.

  • Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement, and financing details for future advancement of the Biliary Tract Cancer market.

Download our free sample page report on Biliary Tract Cancer pipeline insights

Biliary Tract Cancer Emerging Drugs

  • MRG 002: Miracogen

  • Disitamab vedotin: Yantai Rongchang Pharmaceutical

  • Envafolimab: Alphamab Oncology

  • DKN-01: Leap Therapeutics

Biliary Tract Cancer Companies

More than 80 prominent companies are actively developing treatments for biliary tract cancer. Notably, SMT Bio Co., Ltd. has drug candidates in the advanced Phase II/III stage of development.

DelveInsight’s report covers around 80+ products under different phases of clinical development like

  • Late stage products (Phase III)

  • Mid-stage products (Phase II)

  • Early-stage product (Phase I) along with the details of

  • Pre-clinical and Discovery stage candidates

  • Discontinued & Inactive candidates

Biliary Tract Cancer pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as

  • Intravenous

  • Subcutaneous

  • Oral

  • Intramuscular

Biliary Tract Cancer Products have been categorized under various Molecule types such as

  • Monoclonal antibody

  • Small molecule

  • Peptide

Download Sample Pages to Get an in-depth Assessment of the Emerging Biliary Tract Cancer Therapies and Key Companies: Biliary Tract Cancer Clinical Trials and advancements

Biliary Tract Cancer Pipeline Therapeutic Assessment

• Biliary Tract Cancer Assessment by Product Type

• Biliary Tract Cancer By Stage

• Biliary Tract Cancer Assessment by Route of Administration

• Biliary Tract Cancer Assessment by Molecule Type

Download Biliary Tract Cancer Sample report to know in detail about the Biliary Tract Cancer treatment market @ Biliary Tract Cancer Therapeutic Assessment

Table of Content

1. Report Introduction

2. Executive Summary

3. Biliary Tract Cancer Current Treatment Patterns

4. Biliary Tract Cancer – DelveInsight’s Analytical Perspective

5. Therapeutic Assessment

6. Biliary Tract Cancer Late-Stage Products (Phase-III)

7. Biliary Tract Cancer Mid-Stage Products (Phase-II)

8. Early Stage Products (Phase-I)

9. Pre-clinical Products and Discovery Stage Products

10. Inactive Products

11. Dormant Products

12. Biliary Tract Cancer Discontinued Products

13. Biliary Tract Cancer Product Profiles

14. Biliary Tract Cancer Key Companies

15. Biliary Tract Cancer Key Products

16. Dormant and Discontinued Products

17. Biliary Tract Cancer Unmet Needs

18. Biliary Tract Cancer Future Perspectives

19. Biliary Tract Cancer Analyst Review

20. Appendix

21. Report Methodology

Request the Sample PDF to Get Detailed Insights About the Biliary Tract Cancer Pipeline Reports Offering

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Biliary Tract Cancer Clinical Trials, Companies, Therapeutic Assessment, Therapies, Treatment Algorithm, and Pipeline Analysis | Yantai Rongchang Pharmaceutical, RemeGen, EMD Serono, SMT bio Co., Ltd.

Non-hodgkin’s Lymphoma Clinical Trials, Companies, Therapeutic Assessment, Therapies, Treatment Algorithm, and Pipeline Analysis

“Non-hodgkin’s Lymphoma Pipeline”
Non-hodgkin’s Lymphoma Companies are Novartis, AstraZeneca, Genentech, BioInvent, Genmab, SystImmune, Nordic Nanovector, Pacylex Pharmaceuticals, Artiva Biotherapeutics, Inc., Chipscreen Biosciences, Ltd., Timmune Biotech Inc., Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Gilead Sciences, Acerta Pharma BV, Adagene Inc, Conjupro Biotherapeutics, Inc., Rhizen Pharmaceuticals, Juventas Cell Therapy Ltd., and others.

Non-hodgkin’s Lymphoma Pipeline constitutes 200+ key companies continuously working towards developing 220+ Non-hodgkin’s Lymphoma treatment therapies, analyzes DelveInsight.

Non-hodgkin’s Lymphoma Overview:

Non-Hodgkin Lymphoma (NHL) is a cancer of the lymphatic system, commonly affecting the lymph nodes. It encompasses a group of over 86 closely related cancers, collectively known as lymphoid neoplasms, as outlined in the 2016 World Health Organization classification. While these types share common traits, they differ in appearance, molecular features, growth patterns, impact on the body, and treatment responses.

NHL is the seventh most common cancer among adults in the United States, with its incidence nearly doubling between 1975 and 2013. Over 72,000 new cases were estimated in 2016. Symptoms often include swollen lymph nodes (usually painless), fever, night sweats, unexplained weight loss, and fatigue. However, these symptoms can also result from non-lymphoma conditions. Medical attention is recommended if symptoms persist for more than two weeks or are severe enough to disrupt daily life.

“Non-hodgkin’s Lymphoma Pipeline Insight 2025” report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the Non-hodgkin’s Lymphoma Therapeutics Market.

Key Takeaways from the Non-hodgkin’s Lymphoma Pipeline Report

  • DelveInsight’s Non-hodgkin’s Lymphoma pipeline report depicts a robust space with 200+ active players working to develop 220+ pipeline therapies for Non-hodgkin’s Lymphoma treatment.

  • In April 2025, Rituxan (rituximab) was approved for treating various blood cancers, autoimmune diseases, and inflammatory conditions, including follicular lymphoma (FL), non-Hodgkin’s lymphoma (NHL), diffuse large B-cell lymphoma (DLBCL), Burkitt lymphoma (BL), Burkitt-like lymphoma (BLL), mature B-cell acute leukemia (B-AL), chronic lymphocytic leukemia (CLL), rheumatoid arthritis (RA), granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), and pemphigus vulgaris (PV). RITUXAN HYCELA, a formulation combining rituximab with Halozyme’s hyaluronidase human ENHANZE technology, is approved for adults with previously untreated or relapsed/refractory FL, untreated DLBCL, and both untreated and treated CLL.

  • In March 2025, Lantern Pharma began dosing two participants in a Phase Ia/Ib clinical trial for LP-284, an experimental drug for relapsed or refractory NHL. LP-284 is a novel small molecule designed to eliminate cancer cells with mutations in DNA damage repair pathways through a synthetically lethal mechanism.

  • Key Non-hodgkin’s Lymphoma companies such as Novartis, AstraZeneca, Genentech, BioInvent, Genmab, SystImmune, Nordic Nanovector, Pacylex Pharmaceuticals, Artiva Biotherapeutics, Inc., Chipscreen Biosciences, Ltd., Timmune Biotech Inc., Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Gilead Sciences, Acerta Pharma BV, Adagene Inc, Conjupro Biotherapeutics, Inc., Rhizen Pharmaceuticals, Juventas Cell Therapy Ltd., Incyte Corporation, HUYA Bioscience International, SecuraBio, Genor Biopharma Co., Ltd., Kyowa Kirin Co., Ltd., Antengene Therapeutics Limited, Regeneron Pharmaceuticals, Jiangsu HengRui Medicine Co., Ltd., Xynomic Pharmaceuticals, Inc., BioTheryX, Inc., UWELL Biopharma, Kronos Bio, Bio-Thera Solutions, Spectrum Pharmaceuticals, Inc., Aptose Biosciences Inc., Miltenyi Biomedicine GmbH, Precision BioSciences, Inc., Teneobio, Inc., TCR2 Therapeutics, IGM Biosciences, Inc, and others are evaluating new drugs for Non-hodgkin’s Lymphoma to improve the treatment landscape.

  • Promising Non-hodgkin’s Lymphoma pipeline therapies in various stages of development include Mosunetuzumab, Tisagenlecleucel, Capivasertib, BI-1206, HMPL-760, and others.

Non-hodgkin’s Lymphoma Pipeline Analysis

The report provides insights into:

  • The report provides detailed insights into the key companies that are developing therapies in the Non-hodgkin’s Lymphoma Market.

  • The report also evaluates different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Non-hodgkin’s Lymphoma treatment.

  • It analyzes the key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.

  • It navigates the emerging drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.

  • Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement, and financing details for future advancement of the Non-hodgkin’s Lymphoma market.

Download our free sample page report on Non-hodgkin’s Lymphoma pipeline insights

Non-hodgkin’s Lymphoma Emerging Drugs

  • Mosunetuzumab: Hoffmann-la Roche

  • Tisagenlecleucel: Novartis

  • Capivasertib: AstraZeneca

  • BI-1206: BioInvent

  • HMPL-760: Hutchmed

Non-hodgkin’s Lymphoma Companies

More than 200 prominent companies are actively working on developing therapies for Non-Hodgkin Lymphoma. Among them, Hoffmann-La Roche has drug candidates in the most advanced stage of development, Phase III.

DelveInsight’s report covers around 220+ products under different phases of clinical development like

  • Late stage products (Phase III)

  • Mid-stage products (Phase II)

  • Early-stage product (Phase I) along with the details of

  • Pre-clinical and Discovery stage candidates

  • Discontinued & Inactive candidates

Non-hodgkin’s Lymphoma pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as

  • Intravenous

  • Subcutaneous

  • Oral

  • Intramuscular

Non-hodgkin’s Lymphoma Products have been categorized under various Molecule types such as

  • Monoclonal antibody

  • Small molecule

  • Peptide

Download Sample Pages to Get an in-depth Assessment of the Emerging Non-hodgkin’s Lymphoma Therapies and Key Companies: Non-hodgkin’s Lymphoma Clinical Trials and advancements

Non-hodgkin’s Lymphoma Pipeline Therapeutic Assessment

• Non-hodgkin’s Lymphoma Assessment by Product Type

• Non-hodgkin’s Lymphoma By Stage

• Non-hodgkin’s Lymphoma Assessment by Route of Administration

• Non-hodgkin’s Lymphoma Assessment by Molecule Type

Download Non-hodgkin’s Lymphoma Sample report to know in detail about the Non-hodgkin’s Lymphoma treatment market @ Non-hodgkin’s Lymphoma Therapeutic Assessment

Table of Content

1. Report Introduction

2. Executive Summary

3. Non-hodgkin’s Lymphoma Current Treatment Patterns

4. Non-hodgkin’s Lymphoma – DelveInsight’s Analytical Perspective

5. Therapeutic Assessment

6. Non-hodgkin’s Lymphoma Late-Stage Products (Phase-III)

7. Non-hodgkin’s Lymphoma Mid-Stage Products (Phase-II)

8. Early Stage Products (Phase-I)

9. Pre-clinical Products and Discovery Stage Products

10. Inactive Products

11. Dormant Products

12. Non-hodgkin’s Lymphoma Discontinued Products

13. Non-hodgkin’s Lymphoma Product Profiles

14. Non-hodgkin’s Lymphoma Key Companies

15. Non-hodgkin’s Lymphoma Key Products

16. Dormant and Discontinued Products

17. Non-hodgkin’s Lymphoma Unmet Needs

18. Non-hodgkin’s Lymphoma Future Perspectives

19. Non-hodgkin’s Lymphoma Analyst Review

20. Appendix

21. Report Methodology

Request the Sample PDF to Get Detailed Insights About the Non-hodgkin’s Lymphoma Pipeline Reports Offerings

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Non-hodgkin’s Lymphoma Clinical Trials, Companies, Therapeutic Assessment, Therapies, Treatment Algorithm, and Pipeline Analysis

Avazona Ltd.’s ‘Founders in Focus’ Hits #1 Best-Seller on Amazon, Celebrating 14 Elite Entrepreneurs Who Built It Their Way

“Founders in Focus: Stories from 14 Entrepreneurs Who Built It Their Way,” the debut anthology by Avazona Ltd., has officially hit #1 on Amazon in multiple categories. The book captures the raw, real, and radically different journeys of 14 visionary entrepreneurs across diverse industries.

Edinburgh, UK – July 2nd, 2025 – Avazona Ltd., the powerhouse behind some of today’s most visible personal brands, has made a major splash in the publishing world with the launch of Founders in Focus: Stories from 14 Entrepreneurs Who Built It Their Way. Since its release, the book has become an Amazon #1 bestseller, topping charts in Global Marketing, Commerce, Shopping & Commerce Reference, and Business Franchises. Featuring real, unfiltered narratives from entrepreneurs in sectors like healthcare, real estate, tech, coaching, and education, the anthology highlights the grit, detours, and defining moments behind modern success.

The book was born out of a need to separate entrepreneurial hype from what it’s really like, what the book’s creator, TJ Avazona, describes as the “pitfalls.” “We’re drowning in hustle quotes, but what people really need are raw blueprints and unedited maps of what it looks like to fall and get back up,” said TJ. “I wrote this because I wish I had it ten years ago. These are the stories I needed to hear when I was struggling.”

Each chapter offers a lived lesson plan, earned through trial, error, and relentless belief. The book doesn’t promise a straight path, but it does offer guidance. These founders may come from different industries, but their stories echo a shared truth: that persistence, adaptability and courage are the real foundations of success.

TJ’s own evolution reflects the message at the heart of the anthology. His path was not a red carpet to success, it was lined with failed YouTube channels, ghosted pitches, painful rejections and constant reinvention. From roadside penny hunts to leading a million-dollar marketing agency, his story is just one of many that prove success isn’t about getting it right the first time, it’s about continuing anyway.

“Founders in Focus: Stories from 14 Entrepreneurs Who Built It Their Way” is now available on Amazon.

About Avazona Ltd.

Avazona Ltd. is a global PR and marketing agency known for helping entrepreneurs and businesses build credibility and visibility through strategic media placements and personal branding. With a presence in multiple countries, the company leverages its strong network of media contacts to deliver impactful storytelling and elevate client profiles across industries.

About Book Authors

  • Amy Goodson, an award-winning sports dietitian and founder of “The Sports Nutrition Playbook,” shares how pauses in her career, like the 2020 slowdown, became launchpads for her greatest work, reminding us that unconventional paths often lead to unexpected wins.

  • Hillary Seiler, known as “Coach Hill,” turned years of financial struggle and medical debt into a renowned business, “Financial Footwork,” which teaches professional athletes and everyday people how to manage money. Her experience proves that pain can be the blueprint for purpose.

  • Dr. David Kenneth Waldman, education advocate, reveals how failing in pre-med led him to create “To Love Children Educational Foundation International,” which empowers girls through education. His story highlights how the worst setbacks can lead to the most impactful missions.

  • Nick Day, founder of “JGA Recruitment,” took a bold leap during the 2008 economic crisis by specializing in payroll. He shows that niche focus and timely action, even in crises, can lead to big wins.

  • Kenya Lee, a nurse and founder of “Faith In Girls,” turned the stillbirth of her daughter into a movement that empowers women. Her chapter proves that emotional intelligence is the foundation of independence.

  • Ryan Crittenden, a U.S. Army veteran, Ph.D. in Industrial and Organizational Psychology, and founder of “XL Coaching and Development,” explains how naming his self-doubt helped him transform it into a tool for growth. He emphasizes outshining flaws with what works and the importance of making people feel seen and valued for long-term wins.

  • Shailesh Poddar, founder of “Habitat28,” changed the housing industry by making modular homes high-quality. From facing stigma to winning municipal approval, his journey demonstrates how innovation and evidence can change minds and markets.

  • Jessica Coffield, psychologist turned coach, offers a valuable story on turning passion into a business like “Endless Possibilities Life and Business Coaching Services.” She shows how purpose, combined with structure and knowledge, can take flight and create lasting breakthroughs.

  • Michael Holt, luxury real estate expert and co-founder of “The Holt Team,” combines high-quality service with deep client empathy. His approach reveals how relationships fuel long-term success.

  • Henry Criss, a Marine Corps veteran and CEO of “Fraum Health,” left behind government bureaucracy to pursue healthcare. His work in non-surgical pain and wellness care reminds us that risks, not routines, lead towards revolutionary leadership.

  • Dr. Adebola Ajao, an FDA epidemiologist and leadership coach, found her calling after career burnout. Through “Empowering Initiatives,” she mentors women to rise beyond professional stagnation, showing that science-backed purpose is a powerful force for reinvention.

  • Philip Shalala, founder of “The Critical Co.” and the branding mastermind behind a major hospitality brand’s entertainment empire, built businesses by following his gut. From launching a top-selling energy drink to selling his entertainment company to a national sports organization, Philip’s story is proof that innovation succeeds when you trust your instincts and dare to disrupt.

  • Rich Funk, CEO of “BOOM Chaga” and a veteran of leading global consumer goods companies, turned COVID-era grief into a mission for wellness. His chapter proves how tragedy and personal loss can awaken world-changing innovation.

  • Christian Cassarly, founder of “SuperpowerThinking.org,” combines trading, mindset mastery, and faith to help others achieve financial and spiritual freedom. He proves that vision and belief can transform uncertainty into impact and profit into purpose.

Media Contact
Company Name: Avazona Ltd
Contact Person: Zach Miller
Email: Send Email
City: Edinburgh
Country: United Kingdom
Website: https://avazona.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Avazona Ltd.’s ‘Founders in Focus’ Hits #1 Best-Seller on Amazon, Celebrating 14 Elite Entrepreneurs Who Built It Their Way

The Boulder Group Arranges Sale of Net Leased Chipotle Property in the Chicago MSA

Randy Blankstein and Jimmy Goodman of The Boulder Group represented the seller in the transaction.

The Boulder Group, a net leased investment brokerage firm, completed the sale of a single tenant net leased Chipotle property located at 1399 W Lincoln Highway in Chicago Heights, Illinois for $2,704,717.

The newly constructed Chipotle drive-thru is operating under a new 15-year lease term with 10% rental escalations every 5 years and four 5-year renewal options.

The property is strategically positioned at the signalized intersection of Western Avenue and Lincoln Highway (34,800 VPD), less than four miles from Interstate 57 (85,900 VPD). Retailers nearby include Walmart, ALDI, Food4Less, O’Reilly Auto Parts, Oak Street Health, Fifth Third Bank, McDonald’s, Wendy’s, and Smoothie King. The population exceeds 169,000 within a 5-mile radius with an average household income of approximately $90,000.

Randy Blankstein and Jimmy Goodman of The Boulder Group represented the seller in the transaction. The buyer is a 1031 exchange investor based in California and the seller is a Midwest-based commercial real estate company.

Chipotle Mexican Grill, Inc., often referred to simply as Chipotle, is a prominent American chain of fast-casual restaurants specializing in tacos and Mission-style burritos. Founded in 1993 by Steve Ells in Denver, Colorado, the company has grown significantly, operating3,752 locations worldwide as of 2025. Chipotle is renowned for its commitment to using high-quality ingredients and promoting food sustainability, evidenced by its “Food with Integrity” philosophy, which emphasizes the use of organic produce, naturally raised meat, and dairy from pasture-raised cows. Headquartered in Newport Beach, California, Chipotle has become a leader in the fast-casual dining sector, distinguished by its customizable menu and efficient service model.

“Newly constructed Chipotle assets with 15-year leases continue to garner significant private investor interest,” said Randy Blankstein, President of The Boulder Group. Jimmy Goodman, Partner of The Boulder Group, added, “Single tenant assets with absolutely no landlord responsibilities are the most sought after assets for 1031 exchange investors.”

About The Boulder Group

The Boulder Group is a boutique investment real estate service firm specializing in single tenant net lease properties. The firm provides a full range of brokerage, advisory, and financing services nationwide to a substantial and diversified client base, which includes high net worth individuals, developers, REITs, partnerships and institutional investment funds. Founded in 1997, the firm has arranged the acquisition and disposition of over $9 billion of single tenant net lease real estate transactions. From 2013-2024, the firm was ranked in the top 10 companies in the nation for single tenant retail transactions by both Real Capital Analytics and CoStar. The Boulder Group is headquartered in suburban Chicago.

More info: www.bouldergroup.com

Media Contact
Company Name: The Boulder Group
Contact Person: Randy Blankstein
Email: Send Email
Phone: 8478816388
Address:3520 Lake Avenue Suite 203
City: Wilmette
State: Illinois
Country: United States
Website: https://www.bouldergroup.com/NNN-Properties-For-Sale.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: The Boulder Group Arranges Sale of Net Leased Chipotle Property in the Chicago MSA

Humic-based Biostimulants Market Trends, Growth Drivers, Key Segments, Top Companies, and Forecast

“MarketsandMarkets™”
Humic-based Biostimulants Market Size, Share, Industry Growth Analysis, Trends Report by Type (Humic Acid, Fulvic Acid, Potassium Humate), Application (Seed Treatment, Soil Treatment, Foliar Spray), Form, Crop Type, and Region (North America, Europe, APAC South America, Row) – Global Forecast to 2027

The global humic-based biostimulants market was valued at USD 686 million in 2022 and is projected to reach USD 1,184 million by 2027, growing at a CAGR of 11.5% during the forecast period. Humic-based biostimulants include key active ingredients such as humic acids, fulvic acids, and potassium humate. These compounds are increasingly recognized for their complementary role alongside crop nutrition and protection products, driving global demand among growers. As consumer preference shifts toward sustainably grown food with reduced reliance on synthetic chemicals, humic-based biostimulants are gaining prominence for their ability to boost plant growth and resilience under stress in an environmentally responsible manner.

 

Humic-based Biostimulants Market

 

Why Humic-Based Biostimulants?

Humic substances improve nutrient uptake, stimulate root development, and enhance soil microbial activity—factors critical to modern, high-efficiency farming. Farmers and agribusinesses are increasingly incorporating these biostimulants into their crop management systems due to benefits such as:

  • Enhanced soil fertility and structure
  • Increased crop yield and quality
  • Improved water retention and nutrient efficiency
  • Reduced environmental impact

 

Humic-based Biostimulants Market Growth Drivers

  • Sustainable Agriculture Trends: Farmers and agri-businesses are under growing pressure to adopt sustainable practices. Humic substances contribute to this goal by increasing nutrient use efficiency and reducing the environmental impact of conventional agrochemicals.
  • Soil Health Restoration: Continuous cultivation and excessive chemical use have led to soil degradation across many regions. Humic biostimulants help rejuvenate soil by improving its organic matter content and microbial balance.
  • Government and Policy Support: Numerous countries are promoting organic farming through subsidies, certification schemes, and education programs. Such policy frameworks have indirectly boosted demand for natural biostimulants, including humic-based products.
  • Rising Demand for High-Quality Crops: The market is also benefiting from a growing consumer preference for clean-label, residue-free food. This has encouraged farmers to seek inputs that improve crop quality without chemical residues.

 

Liquid formulations to dominate market growth during the forecast period

Liquid humic-based biostimulants are expected to witness the fastest growth due to their ease of application and versatility. Farmers prefer liquid formulations because they are easier to handle and can be readily mixed with other agricultural inputs such as fertilizers, pesticides, and adjuvants. Manufacturers are increasingly catering to this preference by offering more liquid-based products. These formulations are valued for their extended efficacy and superior performance compared to dry forms. However, they also vary in application method, rate, and environmental impact depending on their specific characteristics.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=45726696

Fruits and vegetables segment to register the highest CAGR by crop type

Among crop types, fruits and vegetables are projected to experience the fastest growth in demand for humic-based biostimulants. As high-value crops, they require significant investment to ensure yield quality and quantity. Humic-based biostimulants improve fruit development, increase yield, and enhance attributes such as size, color, and sugar content. They also reduce fruit drop and accelerate ripening. In vegetables, these products contribute to larger produce, better shelf-life, improved pest resistance, and heightened antioxidant activity. For leafy vegetables, they promote root growth, chlorophyll and carotenoid levels, and maintain nitrate content within EU-regulated limits. These benefits make humic-based biostimulants essential for enhancing plant vigor and fertility in these intensive crop systems.

Asia Pacific to lead regional market growth

The Asia Pacific region is expected to grow at the highest CAGR in the humic-based biostimulants market during the forecast period. The Asia-Pacific Plant Protection Commission (APPPC) has been instrumental in advancing Integrated Pest Management (IPM)—an ecologically sound alternative to conventional chemical use. Through programs such as Farmer Field Schools, FAO-supported IPM initiatives, and regional collaborations, IPM practices are being scaled across the region. With increasing concerns over soil degradation caused by intensive agriculture and chemical overuse, agencies like the FAO now advocate the use of biostimulants and bioinoculants to restore soil health. Over the past two decades, this shift has resulted in a marked increase in biostimulant adoption and a decline in the use of traditional chemical fertilizers across the region.

Leading Humic-based Biostimulants Companies:

The key players in this market include Koppert (Netherlands), Valagro SpA (Italy), Biolchim S.p.A (Italy), FMC Corporation (US), Haifa Group (Israel), UPL Ltd. (India), Bayer AG (Germany), SIKKO INDUSTRIES LTD (India), NOVIHUM Technologies GmbH (Germany), HUMINTECH GMBH (Germany), and BORREGAARD (Norway).

Key Questions Addressed by the Humic-based Biostimulants Market Report:

  1. What are humic-based biostimulants?
  2. What is driving the growth of the humic-based biostimulants market?
  3. What is the current market size and growth forecast for humic-based biostimulants?
  4. What are the primary applications and end-users?
  5. What are the main types of humic-based biostimulants?
  6. Which regions are leading the market?
  7. Who are the key players in the humic-based biostimulants market?
  8. What innovations are emerging in the market?
  9. What trends are shaping the future of the humic-based biostimulants market?

 

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America’s Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the ‘GIVE Growth’ principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/humic-based-biostimulants-market-45726696.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Humic-based Biostimulants Market Trends, Growth Drivers, Key Segments, Top Companies, and Forecast

Digital Transformation Market Growth Outlook, Future Scope, Emerging Trends, Technologies, Top Countries Data, Opportunities and Forecast 2030

“IBM (US), Microsoft (US), Google (US), AWS (US), Cisco (US), and some of the key start-ups include Kissflow (US), ProcessMaker (US), Process Street (US), Laiye (China), ElectroNeek (US).”
Digital Transformation Market by Business Transformation (Process, Model, Domain), Technology (Cloud Computing, AI, Big Data Analytics (Predictive, Prescriptive), Blockchain, Cybersecurity (Network, Cloud Security), IoT, RPA) – Global Forecast to 2030.

The global digital transformation market is projected to increase from an estimated USD 911.2 billion in 2024 to USD 3,289.4 billion in 2030, at a compound annual growth rate of 23.9%. Blockchain for decentralized identity management, cybersecurity innovations with zero trust architecture, hyper automation for simplified corporate processes, and Edge AI for on-device intelligence that facilitates real-time decision-making and lowers latency are the main drivers of industry expansion.

Download PDF Brochure@ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=43010479

By Technology, cloud computing to register for the largest market share during the forecast period.

Cloud computing is expected to dominate the digital transformation market as it helps businesses scale, reduce costs, and provide flexible option to quickly adapt to changing demands. As businesses move more towards cloud-based systems, they gain advantages from the integration of AI, big data analytics, and IoT, which leads to innovation and increased efficiency in operations. Key trends in cloud computing include hybrid and multi-cloud environments, edge computing, and serverless architectures. This brings about a new role in the face of digital transformation. Moreover, there is an increasing importance placed on improved security measures and compliance solutions as businesses focus on safeguarding data in their cloud strategies.

By Vertical, BFSI is poised for the fastest growth rate during the forecast period.

The BFSI vertical is anticipated to grow at the fastest rate in digital transformation market due to the pressing need to address issues related to customer experience, operational efficiency, and compliance . Personalized services, fraud detection, and real-time decision-making are at the center of this new paradigm shift in financial services brought about by AI Blockchain, and Advanced Analytics. Key trends include digital banking and the development of different fintech solutions along with the integration of automated procedures like RPA to cut expenses and increase productivity. Additionally, the growing emphasis on cybersecurity and data protection is driving investments in secure digital infrastructure, further propelling the sector’s rapid digital evolution.

By Region, North America accounts for the largest market during forecast period.

North America is projected to hold the largest market share in digital transformation market because to its robust technological infrastructure, high rate of technology adoption, and presence of large tech companies. Businesses in the region are making significant investments in digital transformation in order to boost customer satisfaction, increase operational effectiveness, and maintain a competitive edge over its rivals. Moreover this expansion is fueled by the growing need for cloud computing, artificial intelligence, and IoT solutions as well as the encouraging government regulations and significant R&D investments. The region is also bolstered by a highly skilled workforce and a culture of innovation, positioning North America as a leader in embracing and implementing digital transformation strategies during the forecast period.

Request Sample Pages@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=43010479

Unique Features in the Digital Transformation Market

The digital transformation market stands out due to its comprehensive integration of emerging technologies like Artificial Intelligence (AI), Machine Learning (ML), Internet of Things (IoT), Blockchain, and Cloud Computing. These technologies are not just enhancing operational efficiency but also enabling intelligent automation, real-time analytics, and personalized customer experiences across industries.

Unlike generic IT services, digital transformation offerings are increasingly tailored to specific industry needs—be it healthcare, manufacturing, retail, or financial services. This sector-specific approach drives deeper adoption, as solutions are designed around unique regulatory, operational, and customer demands.

Customer experience has become a critical driver of digital transformation. The market uniquely emphasizes omnichannel engagement, personalization, and user experience design. Businesses are leveraging digital platforms to understand customer behavior through data and offer seamless experiences across touchpoints.

A defining feature of the market is the emphasis on real-time data collection, integration, and analysis. By unlocking insights from vast data sources, organizations are making faster and more accurate decisions, improving responsiveness to market changes, and enabling predictive capabilities.

Major Highlights of the Digital Transformation Market

The digital transformation market is experiencing exponential growth across sectors such as BFSI, healthcare, retail, manufacturing, and government. Driven by the need to improve efficiency, customer engagement, and innovation, organizations are heavily investing in digital strategies, making this market one of the most dynamic globally.

Cloud platforms are foundational to digital transformation, providing the flexibility, scalability, and cost-efficiency needed for modern enterprise operations. Public, private, and hybrid cloud adoption is surging, enabling seamless integration of digital tools and services across geographies and departments.

Artificial Intelligence, Robotic Process Automation (RPA), and Machine Learning are increasingly being adopted to automate workflows, enhance analytics, and improve decision-making. This automation wave is helping businesses reduce operational costs and increase agility in responding to market changes.

The pandemic acted as a catalyst for digital transformation, accelerating adoption timelines. Remote work, digital payments, virtual healthcare, and e-commerce growth all highlighted the need for resilient digital infrastructures, permanently shifting enterprise priorities toward digital-first models.

Inquire Before Buying@ https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=43010479

Top Companies in the Digital Transformation Market

The major players in the digital transformation market include IBM (US), Microsoft (US), Google (US), AWS (US), Cisco (US), and some of the key start-ups include Kissflow (US), ProcessMaker (US), Process Street (US), Laiye (China), and ElectroNeek (US).

Microsoft (US)

Microsoft is one of the leaders in the digital transformation market, leveraging its robust portfolio of cloud, AI, and productivity solutions. Microsoft Azure which is a very powerful cloud platform offers flexible scaling capabilities thereby enabling businesses to handle data management and develop new applications. Azure’s machine learning and AI helps in advanced analytics, thus aiding intelligent decision-making by facilitating automation for improved efficiency among industries. Microsoft 365 enhances collaboration as well as communication using integrated tools such as Teams and SharePoint that facilitate remote working or hybrid office arrangements. Microsoft Dynamics 365 application provides consolidated ERP & CRM solutions for improving business operations while improving customer experience. Microsoft has made significant investments on securing protocols and regulations that distinguish it from other companies regarding adoption of digital transformation.

AWS (US)

Amazon Web Services (AWS) is widely known for its comprehensive and flexible cloud services, making it one of the leaders in the digital transformation market. AWS offers a wide range of solutions and services that help businesses innovate, grow, and adjust quickly in the digital era. The strong infrastructure-as-a-service (IaaS) platform allows businesses to move legacy systems to the cloud, spend efficiently, and improve operational flexibility. Key solutions such as AWS Lambda for serverless computing, Amazon SageMaker for AI & machine learning, and Amazon Redshift for data warehousing support advanced data analysis, automation, and customized customer interactions. AWS offers security, compliance, and hybrid cloud options that allow businesses to safely and effectively upgrade their operations, playing a key role in the digital transformation of various industries.

IBM (US)

IBM offers a range of innovative solutions designed to help businesses modernize and thrive in the digital era. With IBM’s hybrid cloud and AI-driven platforms, IBM enables organizations to seamlessly integrate legacy systems with new digital capabilities. IBM Cloud, combined with Red Hat OpenShift, provides a flexible and scalable environment for developing, deploying, and managing applications across public and private clouds. IBM’s Watson AI services empower companies to harness the power of data through advanced analytics, natural language processing, and machine learning, driving smarter decision-making and automation. Additionally, IBM’s blockchain and quantum computing initiatives push the boundaries of digital innovation, offering cutting-edge tools for secure transactions and complex problem-solving. These offerings solidify IBM’s role as a trusted partner in the digital transformation journey across industries.

SAP (Germany)

SAP (Germany) is a prominent leader in the digital transformation market, providing comprehensive enterprise software solutions that enable businesses to streamline processes, enhance data analytics, and drive innovation. Their cloud-based platforms help organizations improve agility, scalability, and efficiency in the ever-evolving digital landscape.

Salesforce (US)

Salesforce (US) is a leader in the Digital Transformation market, providing cloud-based customer relationship management (CRM) solutions that help organizations streamline operations, improve customer engagement, and drive innovation. Their platform enables businesses to integrate data, automate processes, and enhance collaboration across departments to accelerate digital transformation.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/digital-transformation-market-43010479.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Digital Transformation Market Growth Outlook, Future Scope, Emerging Trends, Technologies, Top Countries Data, Opportunities and Forecast 2030

Autonomous Enterprise Market Latest Trends, Outlook, Global Size, Share, Applications, Advance Technology And Forecast – 2029

“Microsoft(US), IBM (US), Check Point (US), Pegasystems (US), Cisco (US), SAP (Germany), Atos (France), AWS (US), Oracle (US), HPE (US), Sage (UK), NICE (Israel), Palo Alto Networks (US), Blue Prism (UK), UiPath (New York), Appian (US), Automation Anywhere (US), Tangentia (Canada), Drivenets (Israel).”
Autonomous Enterprise Market by Solutions (Robotic Process Automation, Autonomous Networks, Accounts Automation, Security Automation), Business Functions (IT, Sales & Marketing, Supply Chain & Operations, Accounting & Finance) – Global Forecast to 2029.

The autonomous enterprise market is expected to expand at a compound annual growth rate (CAGR) of 17.6% from USD 50.5 billion in 2024 to USD 114.0 billion by 2029. Demand for autonomous businesses is being driven by numerous industries’ growing need for automation, efficiency, and optimization. IT & ITeS, logistics, BFSI, retail, and eCommerce are among the industries looking for creative ways to cut expenses, increase efficiency, and streamline operations.

Download PDF Brochure@ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=80775550

Governance of enterprises by autonomous systems is essential in autonomous enterprises, supported by the number of IoT devices and the enhancement of edge computing. Since IoT devices are penetrating deeper into all the facets of life, they continue to produce huge amounts of data in real time, giving organizations valuable insights into their functioning, customers, and environment. This data, however, needs to be analyzed quickly to make the information as helpful as possible. To meet this need, advances in edge computing have been made more continuous to bring computation nearer to the data source for efficiency, and reduced dependence on cloud central structures. In addition to improving the velocity of data ingestion and reliability of data analysis, this approach also improves security and privacy by ‘pushing’ data closer to the edges. Combined, IoT and edge computing provide significant support to autonomous enterprises to adapt to change in real-time, capture insight, make decisions quickly, and dynamically adjust processes and operations to reflect the environment in which they exist. Most of these technologies are critical for achieving autonomous business operations that define the future autonomous enterprise.

The autonomous agent’s solution is projected to register the highest CAGR during the forecast period.

Autonomous agents are highly developed AI systems that perform specific tasks without human intervention or assistance. These agents use a chain of thought logic that enables them to break down intricate problems into manageable subtasks solved with little or no interface by a human being. Large language models can be used by autonomous agents to process different input data and build the resources needed to perform these subtasks. These agents residing and functioning within their interfaces as bots or perhaps controlling physical robots make API calls to the actual real world, access information and data, use other software, and also maintain physical entities and objects. Intentionally created to accomplish specific goals, autonomous agents exist and perform their operations only within specific allowed parameters set by the design and permissions given at the outset.

The uninterrupted development of AI technology makes AI agents’ capabilities far beyond the current bounds. Some of the future AI agents will have a better understanding of human language, which, in the long run, can make it very intuitive and natural to interact with such agents. Bringing quantum computing to join AI can exponentially increase the processing power available to AI agents, assisting them in solving complex problems much more effectively and elevating their learning abilities. On the other hand, developments in explainable AI aim to make the process of decision-making of an AI agent more transparent to humans.

Based on region, Asia Pacific is projected to register the highest CAGR during the forecast period.

The autonomous enterprise market in the Asia Pacific includes China, Japan, ANZ, South Korea, India, and the Rest of Asia Pacific; the rest of Asia Pacific includes countries such as Singapore, Malaysia, Thailand, and the remaining countries in Asia Pacific. China, Japan, Australia, and India are the major countries driving the Asia Pacific autonomous enterprise market. Adopting Al technology in different verticals, such as the BFSI, travel and hospitality, and retail, is expected to contribute to the high growth of the autonomous enterprise market. Rapid economic development, globalization, digitalization, and the increased adoption of cloud-based technologies are expected to drive the growth of the autonomous enterprise market in the Asia Pacific region. Asia Pacific has been one of the fastest-growing autonomous enterprise market regions due to the rising solutions and services adoption across the healthcare, pharma, IT and Telecom, manufacturing, and retail industries. Further, rising automation demand in the Business Process Outsourcing (BPO) sector and rising knowledge of automation among various industries and SMEs impact the region’s favorable market growth. The trend is expected to gain traction with the growing presence of autonomous enterprise providers, such as Blue Prism’s geographical expansion in the region.

Request Sample Pages@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=80775550

Unique Features in the Autonomous Enterprise Market

Autonomous enterprises leverage advanced AI and machine learning algorithms to make real-time decisions with minimal human intervention. These systems continuously learn and adapt from internal and external data, enabling predictive and prescriptive analytics that streamline operations, reduce costs, and enhance agility.

A defining feature is the ability to automate entire business processes across departments — from finance and HR to supply chain and customer service. This includes integrating robotic process automation (RPA), intelligent document processing, and workflow orchestration, ensuring consistent and error-free execution.

Autonomous enterprises employ self-monitoring IT systems that detect, diagnose, and resolve issues automatically. These self-healing capabilities minimize downtime, enhance system resilience, and reduce the need for manual IT intervention, thus maintaining business continuity.

They offer highly personalized and proactive customer experiences by utilizing natural language processing (NLP), sentiment analysis, and AI-powered chatbots. These tools anticipate customer needs, provide real-time assistance, and resolve queries without human involvement.

Major Highlights of the Autonomous Enterprise Market

The autonomous enterprise market is witnessing accelerated growth as organizations increasingly invest in AI and automation to enhance operational efficiency. Industries such as finance, healthcare, manufacturing, and retail are leading adopters, driven by the need to reduce costs and improve responsiveness.

There is a rising demand for integrating artificial intelligence (AI) and machine learning (ML) across business functions. Enterprises are leveraging these technologies not just for analytics but for real-time decision-making, operational optimization, and predictive planning.

Cloud-native platforms and edge computing play a pivotal role in enabling autonomous functions by offering scalable infrastructure and real-time data processing capabilities. This allows enterprises to deploy intelligent systems closer to the point of action, ensuring faster insights and response.

Hyperautomation, which combines RPA, AI, process mining, and other tools, is a key market driver. Enterprises are moving beyond isolated automation to automate entire workflows end-to-end, transforming both customer-facing and back-office operations.

Inquire Before Buying@ https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=80775550

Top Companies in the Autonomous Enterprise Market

The report profiles key players such as Microsoft(US), IBM (US), Check Point (US), Pegasystems (US), Cisco (US), SAP (Germany), Atos (France), AWS (US), Oracle (US), HPE (US), Sage (UK), NICE (Israel), Palo Alto Networks (US), Blue Prism (UK), UiPath (New York), Appian (US), Automation Anywhere (US), Tangentia (Canada), Drivenets (Israel), Nintex (US), Synder (US), Fetch.ai (England), AutomationEdge (US), Rocketbot (Chile), Rossum (UK), Digitate (US), and Mendix (US).

Pegasystems empowers the world’s top organizations with business-transforming results and provides a firm platform for delivering real-time optimization. Clients use its enterprise AI decisions and workflow automation to solve their most pressing business challenges to solve the most pressing business problems, from personalized engagement and automation of service to streamlining operations. Pega is a recognized leader in customer engagement, customer service, CRM, and BPM, as well as operational excellence, robotics, AI, and digital process automation. The Comprehensive Pegasystems Platform has the following capabilities: App Development, Decision Hub, Mobile, BPM and Case Management, Data and Integrations, and Robotic Automation and Intelligence. The company is active and has a substantial collection of products, solutions, and services for the autonomous enterprise market. It also provides several products, which include the low-code platform, RPA, and case management under the larger category of intelligent automation. The solutions support companies in automating business processes by providing a unified, no-code valuable platform across various industries. Its solutions, from financial services to health care, help customers make fact-based decisions and get work done with real-time AI and intelligent automation.

Check Point is a player in the cybersecurity field, offering cutting-edge solutions driven by AI to safeguard more than 100,000 organizations globally. Using AI technology, their Infinity platform enhances security effectiveness and precision, allowing for threat detection at a pace. Check Point provides a range of cloud, network, mobile, endpoint, and IoT security products and services, all within the framework known as the Infinity architecture. This approach simplifies management and deployment processes and delivers real-time threat insights. Ensures automatic updates for enhanced security measures.

Microsoft is a key player in the autonomous enterprise market, leveraging AI, automation, and cloud technologies through platforms like Azure AI, Power Automate, and Dynamics 365. Its solutions enable intelligent decision-making, process automation, and self-optimizing business operations across industries, enhancing efficiency and innovation.

IBM is a prominent player in the autonomous enterprise market, offering AI-driven solutions like Watson and IBM Cloud Pak to automate business processes, enhance decision-making, and optimize operations. Its tools enable enterprises to implement self-managing systems, improve efficiency, and drive innovation across industries.

SAP is a key player in the autonomous enterprise market, providing AI-powered solutions like SAP S/4HANA and SAP Intelligent Robotic Process Automation. These tools help businesses automate processes, enhance decision-making, and drive efficiency, enabling self-optimizing operations and seamless integration across enterprise systems.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/autonomous-enterprise-market-80775550.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Autonomous Enterprise Market Latest Trends, Outlook, Global Size, Share, Applications, Advance Technology And Forecast – 2029

205 Heating & Cooling Brings Affordable HVAC Services to Rural Birmingham Communities as Industry Prices Soar

Pell City, AL – July 2, 2025 – 205 Heating & Cooling LLC, a locally-owned and operated HVAC company, is helping rural homeowners in the Greater Birmingham area access affordable, high-quality heating and cooling services by offering a lower-cost alternative to larger urban contractors whose higher overhead often drives up prices for consumers.

Since 2020, the HVAC industry has experienced a reported 40% increase in equipment and installation costs due to supply chain disruptions and inflation, placing significant pressure on homeowners seeking system upgrades, repairs, or new installations. To address this, 205 Heating & Cooling has maintained a lean business model that enables the company to keep prices low for rural and underserved areas of the region.

“We’re committed to making HVAC services more accessible and affordable for families in rural Alabama,” said Kevin Self, the Owner and CEO of 205 Heating & Cooling LLC. “By operating lean and locally, we’re able to deliver the same quality service for major HVAC brands at a lower price point compared to big-city contractors.”

The company’s service model is intentionally structured to prioritize rural homeowners, many of whom are often overlooked by major HVAC providers. By focusing on operational efficiency and community engagement rather than high-volume growth, the company is helping close the gap in access to reliable heating and cooling systems.

Moreover, as a certified Smart Financing service provider through Alabama Power, 205 Heating & Cooling enables homeowners to take advantage of energy-efficient upgrades without large upfront costs. This financing option allows customers to make monthly payments through their power bill. For rural households with limited contractor access or financing options, this offers a critical solution to more sustainable and comfortable living conditions.

“Many rural families don’t realize they have options outside of high-priced metro contractors,” added Self. “We want to change that by offering dependable service, real savings, and the peace of mind that comes from working with a local expert who puts people over profit.”

The company serves areas across Birmingham and St. Clair County with over 35 years of industry experience. Its technicians work on all major HVAC brands and systems, offering full installations, repair, and maintenance services tailored to the needs of rural homeowners.

For more information about 205 Heating & Cooling, please visit https://205heatingcooling.com/ or call (205) 365-5978.

Socials: 205heatingcooling

Media Contact
Company Name: 205 Heating & Cooling LLC
Contact Person: Kevin Self
Email: Send Email
Phone: (205) 365-5978
Country: United States
Website: https://205heatingcooling.com/

Christela the Godtop: A Voice of Faith, Fire, and Hip-Pop Innovation

From the heart of Haiti to the global stage, Christela the Godtop is more than just a name—it’s a testament to resilience, divine guidance, and unwavering creative spirit. A singer-songwriter with roots in church music, Christela merges the soulful energy of gospel with the bold textures of hip-hop and pop to create her own distinct genre: hip-pop.

“Hi, I’m Christela the Godtop a artist and singer-songwriter with a roots in church music. I’ve been singing since I was 2 years old, I’ve always known that music was my passion. Now , as a singer, I’m bringing my own unique sound to the stage, and now I’m excited to share my music to the world and connect with like – minded people – and see where this journey takes me“

From Pain to Purpose: The Origin of “Christela the Godtop”

Her stage name tells a story. After enduring serious health battles and traumatic accidents, Christela says she felt guided by a higher power—so she chose to wear that faith in her name.

“Christela the Godtop reflects my journey. It represents my gratitude and faith, which inspires everything I do artistically.”

The Haitian Soul Meets Global Sound

Born in Haiti, Christela’s musical foundation was built at an early age. She started making music at just 7 years old, with her earliest performances shaped by the rich harmonies and spiritual roots of church choirs. That spiritual core is still present in her music today—but now, it’s paired with sleek beats, dynamic hooks, and hip-pop swagger.

Inspiration Runs in the Family—and Beyond

When asked about her influences, Christela lights up, naming powerhouse women who’ve shaped her sound and spirit.

“My biggest inspirations are my sister Sabine, Beyoncé, Rihanna, my little sister Sarai ‘the queen,’ and Celeste ‘the powerful.’ Each brings something unique—Sabine’s creativity, Beyoncé’s empowerment, Rihanna’s versatility, Sarai’s youthful vibe, and Celeste’s strength.”

This blend of personal and pop culture influence gives Christela a rare authenticity in an often image-driven industry.

Music That Heals, Music That Speaks

For Christela, success isn’t just measured in streams or followers—it’s in impact.

“The best compliment I’ve ever received was when someone said my song helped them through a tough time. Another fan told me my music ‘speaks to their soul.’ That’s what drives me.”

Her music is deeply emotional, often inspired by hardship. She doesn’t shy away from acknowledging how difficult moments bring out the most powerful lyrics.

“Yes, I believe some of our best songs come from pain. I’ve drawn inspiration from tough experiences, and it’s helped me connect with others through my art.”

Creating, Anywhere and Everywhere

Despite her rising profile, Christela keeps her process simple.

“I’m flexible and can work from anywhere, but I prefer my home.”

Legacy in Motion

Above all, Christela the Godtop wants to be remembered as someone who inspired others and made a difference—through both her music and her message.

“My legacy would be one of creativity, innovation, and leaving the world better than I found it.”

Follow Christela the Godtop for updates on her latest releases and performances as she continues redefining what hip-pop sounds—and feels—like. She’s not just here to entertain. She’s here to elevate.

Media Contact
Company Name: Christela The Godtop
Contact Person: Media Manager
Email: Send Email
City: Queens
State: New York
Country: United States
Website: https://celebrityhiphop.com/